On June 22, the PMDA held the “PMDA-ATC Good Registration Management (GRM) Webinar 2022 for CDSCO”. This webinar was designed for staff members of the Central Drugs Standard Control Organization (CDSCO), India, who are engaged in review of pharmaceuticals. A total of 40 CDSCO regulators was participated in it.
The PMDA and CDSCO exchanged their views regarding the importance of pre-application consultation as well as the acceptance of overseas clinical trials in line with post-marketing requirements.
The PMDA continues to promote collaboration with CDSCO through training seminars and other activities etc.
See attached program
Back
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
International Activities
Safety Information
Advanced Efforts
-
Information for approved products in Japan
Safety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
Regulatory science
-
Regulations and services of PMDA
Information for approved products in Japan
Procedures in Japan
Advanced efforts
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
Safety information
Procedures in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
Safety information
Procedures in Japan
-
Reviews and Related Services
Regulatory Procedures
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety
Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC Good Registration Management (GRM) Webinar 2022 for CDSCO
Events and Symposia